Journal of Hematology and Transfusion

Cardiovascular Risk Factors and Venous Thromboembolism: Is there a Connection?

Research Article | Open Access

  • 1. Department of Hematology, Division of Hemostasis and Thrombosis, University Hospital Fundación, Spain
+ Show More - Show Less
Corresponding Authors
A García-Raso, Division of Hemostasis and Thrombosis, Department of Hematology, University Hospital Fundación Jiménez Díaz, Avenida de los Reyes Católicos, nº2. 28040. Madrid. Spain, Tel: 34 915504800, ext. 3142; Fax: 3491546670

Background: Arterial thrombosis and venous thrombosis are medical conditions with high levels of morbidity and mortality, especially in developed countries. It has not yet been established if these disorders have physiopathological mechanisms in common. Dyslipidemia, hypertension, diabetes mellitus, and smoking have been investigated as possible risk factors for these pathologies, although their impact on venous thrombosis remains unknown.

Subjects and methods: We studied a group of 453 patients, 201 with VTE, and 252 patients with CVD (cases of cardioembolic stroke were excluded). A control group consisting of 346 subjects with no history of arterial thrombotic disease, VTE or cancer was also included in the study. All patients and controls were evaluated for the presence of the following risk factors: hypertension; Diabetes mellitus; dyslipidemia; smoking.

Results: All the risk factors included in the present study (hypertension, diabetes mellitus, dyslipidemia, and smoking) were associated with elevated risk of Cardiovascular Diseases CVD. Patients with alterations in the lipid profile had a higher risk of Venous Thromboembolism VTE (OR: 1.62, 95%CI: 1.04-2.52, p= 0.03), whereas subjects who smoke presented twice the risk of venous thrombosis (OR: 2.28, 95%CI: 1.49-3.48, p=0.0001).

After adjusting for age and sex, when we compared the two patient groups and controls, the multivariable analysis showed that dyslipidemia was a risk factor for VTE (OR: 1.66, 95% CI: 1.06-2.61, p=0.027), and it was not related with CVD (OR: 1.29, 95% CI: 0.84-1.98, p: ns).

Conclusion: Arterial and venous thrombosis share common risk factors such as dyslipidemia, HTA, and smoking.


García-Raso A, Santos Montero AB, Ene GS, Llamas Sillero P (2013) Cardiovascular Risk Factors and Venous Thromboembolism: Is there a Connection? J Hematol Transfus 1(2): 1009.


•    Cardiovascular risk factor
•    Venous thrombosis


Traditionally, arterial thrombosis and venous thrombosis have been considered as two distinct pathophysiological entities. In recent years, however, a possible association between venous and arterial thrombosis has been studied. Endothelial injury, inflammatory markers, and impaired fibrinolysis play an important role in the physiopathology of these entities. On the other hand, venous and arterial thrombosis shares certain cardiovascular risk factors, such as obesity, diabetes mellitus, hypertension, and hypertriglyceridemia, although this is still a controversial aspect [1]. In addition, there are some clinical conditions that favor the development of both venous and arterial thrombosis, such as hyperhomocysteinemia, antiphospholipid syndrome (APS), paroxysmal nocturnal hemoglobinuria, infections, myeloproliferative disorders, or hormonal therapy [2,3].

Different studies have analyzed the risk of venous thrombosis in patients with arterial disease, while others have described the risk of arterial disease in patients with venous thrombosis. Prandoni et al. studied a group of 299 patients diagnosed with venous thrombosis who did not have symptomatic atherosclerosis. The authors report that the presence of carotid plaques in patients with unprovoked VTE compared with secondary VTE and controls yielded an odds ratio (OR) of 2.3 and 1.8, respectively [4]. Later, the same researchers reported on a prospective study showing that patients with idiopathic VTE had a 60% higher risk of arterial events than those with secondary VTE [5]. Bova et al., compared the incidence of subsequent arterial events in 151 consecutive patients with idiopathic VTE and a control group [6]. They concluded that arterial events were more common in patients with VTE. These results were not confirmed by other investigators, who hypothesize that conditions resulting from atherosclerosis may predispose people to VTE because of another associated morbidity, like hospitalizations or impaired mobility [7,8].


We performed a case-control study to investigate the association between the classical cardiovascular risk factors (smoking, dyslipidemia, hypertension and diabetes mellitus) in 2 groups of patients, one with ischemic cerebrovascular disease (CVD) and another with venous thromboembolic disease (VTE). The study was approved by the Ethics Committee of our hospital.

We studied a group of 453 patients, 201 with VTE, and 252 patients with CVD (cases of cardioembolic stroke were excluded). The diagnosis of VTE was performed using Doppler ultrasound imaging. Pulmonary embolism (PE) was documented using ventilation/perfusion lung scan or computed tomography. Patients with a history of cancer were excluded. Stroke diagnosis was made based on acute onset and persistent neurological symptoms with a compatible cerebral image, once other causes had been ruled out. A control group consisting of 346 subjects with no history of arterial thrombotic disease, VTE or cancer was also included in the study.

All patients and controls were evaluated for the presence of the following risk factors: hypertension (diastolic blood pressure > 90 mmHg, on at least 2 occasions, or the use of hypotensive drugs); diabetes mellitus (fasting glucose level > 126 mg/dl, or the use of anti-diabetic drugs); dyslipidemia (fasting cholesterol level > 220 mg/dl, or high density lipoprotein (HDL) cholesterol level < 35 mg/dl, or total cholesterol/HDL cholesterol ratio > 4.5, or the use of lipid-lowering drugs); smoking (habitual daily intake of >10 cigarettes).

We conducted a descriptive study of the discrete variables (age and sex) and calculated the frequency and percentage of occurrence of each category (dyslipidemia, HTA, DM, and smoking status). For continuous variables, we calculated the descriptive statistics (mean, median, standard deviation, standard error, minimum, and maximum). The percentages were compared using Fisher’s exact test. We calculated the p-value through univariate logistic regression models. All comparisons were made with a significance level of 0.05. The magnitude of the associations was estimated by odds ratio (OR) and confidence intervals at 95% (95%CI). In order to define properly the effect of the different variables, we conducted a multivariate logistic regression analysis adjusting for age and sex as well as those risk factors that could influence the outcome in each case. Statistical analysis of the data was performed using Stata v.10 (StataCorp LP, College Station, TX, USA).


The characteristics of the patients and the control group as well as the distribution of cardiovascular risk factors are shown in Table 1. Venous thrombotic events were divided into 5 groups depending on the location of the thrombus: PE (associated or not with DVT), 44.8% (n = 90); DVT in the lower limbs, 36.8% (n = 74); thrombosis of unusual locations, 11.9% (n = 24); superficial venous thrombosis, 4.5% (n = 9); and upper limb DVT, 2.0% (n = 4).

We analyzed separately the presence of cardiovascular risk factors and classical thrombotic risk in patients with venous thrombosis. In this group of patients, 64.1% had experienced spontaneous thrombotic events, not identifying any of the analyzed risk factors (immobilization, surgery, air travel, pregnancy, hormonal therapy or autoimmune disease). 26.6% of the patients had at least one risk factor, whereas in 9.3% of them, thrombosis was associated with the presence of 2 or more risk factors.

All the risk factors included in the present study (ie, hypertension, diabetes mellitus, dyslipidemia, and smoking) were associated with elevated risk of CVD. In patients with VTE, dyslipidemia and smoking were significantly more frequent than in the control subjects. Patients with alterations in the lipid profile had a higher risk of VTE (OR: 1.62, 95%CI: 1.04-2.52, p= 0.03), whereas subjects who smoke presented twice the risk of venous thrombosis (OR: 2.28, 95%CI:1.49-3.48, p=0.0001).

After adjusting for age and sex, when we compared the 2 patient groups and controls, the multivariable analysis showed that dyslipidemia was a risk factor for VTE (OR: 1.66, 95% CI: 1.06-2.61, p=0.027), and it was not related with CVD (OR: 1.29, 95% CI: 0.84-1.98, p: ns) (Table 1).

The distribution of the risk factors was further analyzed according to age, subgrouping subjects in ≤65 years and >65 years (Table 2). Hypertension was not related with an increased risk of VTE in patients older than 65 years (OR: 1.61; 95%CI: 0.83-3.12; p=0.1617) neither in younger patients (OR: 0.47; 95%CI: 0.23- 0.95; p=0.0321); however, hypertension was a risk factor for CVD only in younger patients (OR: 3.00; 95%CI: 1.66-5.40; p=0.0002). Dyslipidemia was associated with significantly increased risk of thrombosis in younger patients who developed VTE (OR: 2.13; 95%CI: 1.08-4.18; p=0.0266) or CVD (OR: 2.59; 95%CI: 1.53- 4.68; p=0.0013), but not in older patients. Diabetes was a risk factor for CVD patients independently of age, but no association was found for development of a venous thrombotic event (table 2). Finally, smoking was a risk factor for all subgroups of patients independently of age and the type of thrombosis (Table 2).

Table 1: Characteristics of the study population. OR values adjusted for age and sex.

    Patients (%)
(VTE: 201; CVD:252)
Controls (%) (N=346) OR IC (95%) p CVD vs VTE
Age (±SD)
CVD 70.2±15.1 58.2±17.9 1.05 1.03-1.06 <0.0001 <0.0001
VTE 50.6±18.7 0.98 0.97-0.99 0.0001
Sex (women/men)
CVD 117/135 169/177 1.35 0.92-1.99 ns 0.4059
VTE 102/88 0.77 0.53-1.11 ns
CVD 144 (57.1) 113 (32.7) 1.56 1.05-2.29 0.025 <0.0001
VTE 49 (24.5) 1.06 0.65-1.72 ns
CVD 63 (25.0) 32 (9.2) 2.29 1.40-3.81 0.0009 <0.0001
VTE 9 (4.5) 0.64 0.28-1.38 ns
CVD 65 (25.8) 61 (17.6) 3.08 1.92-5.02 <0.0001 0.0330
VTE 71 (35.5) 2.31 1.51-3.54 0.0001
CVD 66 (26.2) 66 (19.1) 1.29 0.84-1.98 ns 0.5845
VTE 47 (23.5) 1.66 1.06-2.61 0.027

Table 2: Prevalence of risk factors according to age.

  ≤ 65 Years > 65 Years
(OR, 95%CI, p)
N= 80
N= 146
p CVD 
(OR, 95%CI, p)
N= 171
(OR, 95%CI, p)
N= 54
Hypertension 3.00; 1.66-5.40; 0.0002 0.47; 0.23-0.95;0.0321 <0.0001 1.48; 0.93-2.340.58- 1.68; 0.0992 1.61; 0.83-3.12: 0.1617 0.8006
Diabetes 5.50; 2.32-13.05; <0.0001 0.62; 0.19-2.05; 0.4295 <0.0001 1.91; 1.09-3.340.58- 1.68;0.022 0.51; 0.18-1.43; 0.1969 0.0056
Smoking 2.84; 1.65-4.89;0.0001 2.25; 1.43-3.56;0.0004 0.4073 2.18; 1.04-4.570.58- 1.68;0.0355 2.64; 1.05-6.65;0.0337 0.6372
Dyslipidemia 2.59; 1.43-4.68; 0.0013 1.10; 0.63-1.93, 0.7333 0.0068 0.99; 0.58-1.68; 0.9643 3 2.13; 1.08-4.18;0.0266 0.0198



Our study showed that arterial thrombosis and venous thrombosis share some cardiovascular risk factors. Our results for arterial thrombosis confirm that vascular risk factors play an important role in this entity, as previously described [9]. Regarding VTE, we have found some noteworthy associations. Smoking and dyslipidemia were a risk factor for both entities independently of age. Nevertheless, dyslipidemia was more prevalent in patients >65 years. On the other hand, hypertension was a risk factor for VTE only in patients ≤65 years.

Some studies show a relationship between atherosclerosis and venous thromboembolism, but the mechanism underling this association is not clear. Cardiovascular risk factors can contribute to the development of venous thrombus, activation of coagulation, to endothelial damage or stasis. Smoking increases fibrinogen levels and can activate the intrinsic pathway through endothelial damage or anoxia [10-14], whereas the diabetes mellitus is associated with decreased fibrinolysis and may contribute to venous stasis [15,16]. Moreover, hypertension is associated with some degree of inflammation and endothelial damage [17]. Diabetes and lipids are associated with a hypercoagulable state and reduced fibrinolytic activity.

Our results agree with those from a case-control study in a Japanese population reporting an association between elevated cholesterol levels and the occurrence of VTE [18,19]. The patients in the Japanese study did not present severe cardiovascular atherosclerotic disease, and therefore the author hypothesized that hypercholesterolemia directly affects the vein wall or causes progressive hemostatic derangement with impaired fibrinolysis. Even though the atherosclerotic process does not take place in the venous system, there seems to be an association between dyslipidemia and the risk of thrombosis [20]. The results obtained by Deguchi et al. in a group of men under 55 years indicated a relationship between alterations in the lipid profile and thrombosis [21]. In addition, results published by Doggen et al. showed decreased thrombotic risk in patients with elevated HDL levels (> 66.1 mg/dl) [22].

Smoking is a well-established risk factor for arterial disease, and one study has confirmed the role of smoking in venous thromboembolism. The “Nurses’ Health Study” found smoking to be an independent risk factor for PE, with a relative risk of 1.9; this risk level increases with higher levels of cigarette intake [23].

Hypertension is well-established such a risk factor for cardiovascular disease, but its role in relation to VTE is controversial. This study has determined the presence of hypertension in 24.5% (n = 49) of patients with VTE, but not statistically significant association was found. Becattini et al. [24] found an OR of 1.9 for hypertension in patients with pulmonary embolism, while in another study of 215 patients showed an association between hypertension and thrombosis, with an odds ratio of 1.2 [25]. However, other publications have not been able to establish relationship with hypertension [1]. For example, in The Copenhagen City Heart Study, no association with elevated systolic pressure was found [26].

Diabetes mellitus is defined as a condition in which the levels of several factors involved in the processes of coagulation and fibrinolysis are altered [15]. The damage, dysfunction and failure of diverse organs that occurs in the long term could lead to other complications associated with an increased risk of VTE [16]. In the series of patients studied was not found association of DM with VTE. The prevalence of DM in the study population was 4.5 % (n = 9). These results confirm previously published that an independent relationship between the two entities are not evidence [16,26,27]. However, other there are studies in which the DM is associated with an increased risk of thrombotic event. In a meta- analysis published in 2008 established an OR of 1.42 for DM [1], while the LITE study reported a hazard ratio (HR) 1.7 [25]. On the other hand, results in a group of 302 patients indicate a thrombotic risk twice as high in individuals with DM [28].

The ARIC study and the Cardiovascular Health Study found that VTE incidence was not associated with smoking, hypertension, or lipid levels [25,29]. Diabetes has been associated with significantly increased risk of VTE, with a 1.7-fold risk (95%CI: 1.2-2.4). Furthermore, in patients with idiopathic first thrombotic event treated with low-dose aspirin following antigoagulant therapy, a reduction is seen in the ratio of major vascular events (myocardial infarction, stroke, or death from cardiovascular accident) [30]. Statins reduce the extrinsic system tissue factor pathway inhibitor, and patients undergoing statin therapy had significantly lower mean levels of D-dimer than those who were not receiving the therapy [31]. Statins have several effects beyond cholesterol lowering, including inhibition of platelet aggregation, oxidation reduction, and anti-inflammatory activity. Some studies support the notion that venous thrombosis is less common in patients being treated with statins than in patients not receiving lipid-lowering therapy [32-34], although this difference may be due to their hypolipidemic effect owing to direct or associated inflammatory pleiotropic effects.


Our results show that arterial and venous thrombosis share common risk factors such as dyslipidemia, HTA, and smoking. Further studies are needed to clarify a possible association between arterial thrombotic and venous thrombotic disease, and to evaluate its implications for clinical practice.


1. Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen PW. Cardiovascular risk factors and venous thromboembolism: a metaanalysis. Circulation. 2008; 117: 93-102.

2. randoni P. Venous and arterial thrombosis: two aspects of the same disease? Eur J Intern Med. 2009; 20: 660-661.

3. Prandoni P, Piovella C, Pesavento R. Venous thromboembolism and arterial complications. Semin Respir Crit Care Med. 2012; 33: 205- 210.

4. Prandoni P, Bilora F, Marchiori A, Bernardi E, Petrobelli F, Lensing AW, et al. An association between atherosclerosis and venous thrombosis. N Engl J Med. 2003; 348: 1435-1441.

5. Prandoni P, Ghirarduzzi A, Prins MH, Pengo V, Davidson BL, Sørensen H, et al. Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis. J Thromb Haemost. 2006; 4: 1891-1896.

6. Bova C, Marchiori A, Noto A, Rossi V, Daniele F, Santoro C, et al. Incidence of arterial cardiovascular events in patients with idiopathic venous thromboembolism. A retrospective cohort study. Thromb Haemost. 2006; 96: 132-136.

7. van der Hagen PB, Folsom AR, Jenny NS, Heckbert SR, O’Meara ES, Reich LM, et al. Subclinical atherosclerosis and the risk of future venous thrombosis in the Cardiovascular Health Study. J Thromb Haemost. 2006; 4: 1903-1908.

8. Reich LM, Folsom AR, Key NS, Boland LL, Heckbert SR, Rosamond WD, et al. Prospective study of subclinical atherosclerosis as a risk factor for venous thromboembolism. J Thromb Haemost. 2006; 4: 1909- 1913.

9. Engström G, Jerntorp I, Pessah-Rasmussen H, Hedblad B, Berglund G, Janzon L. Geographic distribution of stroke incidence within an urban population: relations to socioeconomic circumstances and prevalence of cardiovascular risk factors. Stroke. 2010; 32: 1098-103.

10. Miller GJ, Bauer KA, Cooper JA, Rosenberg RD. Activation of the coagulant pathway in cigarette smokers. Thromb Haemost. 1998; 79: 549-553.

11. Severinsen MT, Kristensen SR, Johnsen SP, Dethlefsen C, Tjønneland A, Overvad K. Smoking and venous thromboembolism: a Danish followup study. J Thromb Haemost. 2009; 7: 1297-1303.

12. Hansson PO, Eriksson H, Welin L, Svärdsudd K, Wilhelmsen L. Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: “the study of men born in 1913”. Arch Intern Med. 1999; 159: 1886-1890.

13. Lindqvist PG, Epstein E, Olsson H. The relationship between lifestyle factors and venous thromboembolism among women: a report from the MISS study. Br J Haematol. 2009; 144: 234-240.

14. Pomp ER, Rosendaal FR, Doggen CJ. Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use. Am J Hematol. 2008; 83: 97-102.

15. Dielis AW, Smid M, Spronk HM, Hamulyak K, Kroon AA, ten Cate H, et al. The prothrombotic paradox of hypertension: role of the renin angiotensin and kallikrein-kinin systems. Hypertension. 2005; 46: 1236-1242.

16. rant PJ. Diabetes mellitus as a prothrombotic condition. J Intern Med. 2007; 262: 157-172.

17. Heit JA, Leibson CL, Ashrani AA, Petterson TM, Bailey KR, Melton LJ 3rd. Is diabetes mellitus an independent risk factor for venous thromboembolism?: a population-based case-control study. Arterioscler Thromb Vasc Biol. 2009; 29: 1399-1405.

18. Kawasaki T, Kambayashi J, Sakon M. Hiperlipidemia: a novel etiologic factor in deep vein thrombosis: Thromb Res. 1995; 79: 147-51.

19. Kawasaki T, Kambayashi J, Ariyoshi H, Sakon M, Suehisa E, Monden M. Hypercholesterolemia as a risk factor for deep-vein thrombosis. Thromb Res. 1997; 88: 67-73.

20. Quist-Paulsen P, Naess IA, Cannegieter SC, Romundstad PR, Christiansen SC, Rosendaal FR, et al. Arterial cardiovascular risk factors and venous thrombosis: results from a population-based, prospective study (the HUNT 2). Haematologica. 2010; 95: 119-125.

21. Deguchi H, Pecheniuk NM, Elias DJ, Averell PM, Griffin JH. High-density lipoprotein deficiency and dyslipoproteinemia associated with venous thrombosis in men. Circulation. 2005; 112: 893-899.

22. Doggen CJ, Smith NL, Lemaitre RN, Heckbert SR, Rosendaal FR, Psaty BM. Serum lipid levels and the risk of venous thrombosis. Arterioscler Thromb Vasc Biol. 2004; 24: 1970-1975.

23. Goldhaber SZ, Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, et al. A prospective study of risk factors for pulmonary embolism in women. JAMA. 1997; 277: 642-645.

24. Becattini C, Agnelli G, Prandoni P, Silingardi M, Salvi R, Taliani MR, et al. A prospective study on cardiovascular events after acute pulmonary embolism. Eur Heart J. 2005; 26: 77-83.

25. Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Polak JF, Folsom AR. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med. 2002; 162: 1182-1189.

26. Holst AG, Jensen G, Prescott E. Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study. Circulation. 2010; 121: 1896-1903.

27. Stein PD, Goldman J, Matta F, Yaekoub AY. Diabetes mellitus and risk of venous thromboembolism. Am J Med Sci. 2009; 337: 259-264.

28. Petrauskiene V, Falk M, Waernbaum I, Norberg M, Eriksson JW. The risk of venous thromboembolism is markedly elevated in patients with diabetes. Diabetologia. 2005; 48: 1017-1021.

29. Chamberlain AM, Folsom AR, Heckbert SR, Rosamond WD, Cushman M. High-density lipoprotein cholesterol and venous thromboembolism in the Longitudinal Investigation of Thromboembolism Etiology (LITE). Blood. 2008; 112: 2675-2680.

30. Brighton TA, Eikelboom JW, Mann K, Mister R, Gallus A, Ockelford P, et al. Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med. 2012; 367: 1979-1987.

31. Kaba NK, Francis CW, Moss AJ, Zareba W, Oakes D, Knox KL, et al. Effects of lipids and lipid-lowering therapy on hemostatic factors in patients with myocardial infarction. J Thromb Haemost. 2004; 2: 718- 725.

32. Ray JG, Rosendaal FR. The role of dyslipidemia and statins in venous thromboembolism. Curr Control Trials Cardiovasc Med. 2001; 2: 165- 170.

33. Herrington DM, Potvin Klein K. Statins, hormones, and women: benefits and drawbacks for atherosclerosis and osteoporosis. Curr Atheroscler Rep. 2001; 3: 35-42.

34. Glynn RJ, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, et al. A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med. 2009; 360: 1851-1861.

Received : 30 Nov 2013
Accepted : 10 Dec 2013
Published : 13 Dec 2013
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
TEST Journal of Dentistry
ISSN : 1234-5678
Launched : 2014
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X